Table 3.
Effect modifier | Exposure | No. of CVD cases | Rate per 1,000 person-years | HR (95% CI) model 1 | HR (95% CI) model 2 |
---|---|---|---|---|---|
Prepregnancy obesity* | No history of GDM and no prepregnancy obesity | 179,385 | 10.78 | 1.0 (Reference) | 1.0 (Reference) |
History of GDM only | 2,651 | 16.85 | 1.69 (1.63–1.76) | 1.43 (1.38–1.49) | |
Prepregnancy obesity only | 3,420 | 13.17 | 1.81 (1.75–1.87) | 1.49 (1.44–1.54) | |
History of GDM and prepregnancy obesity | 364 | 16.76 | 2.29 (2.07–2.54) | 1.76 (1.59–1.95) | |
Multiplicative interaction (GDM × obesity) | 0.75 (0.67–0.84) | 0.82 (0.74–0.93) | |||
P for multiplicative interaction | <0.001 | 0.001 | |||
RERI | −0.21 (−0.46 to 0.04) | −0.16 (−0.36 to 0.03) | |||
P for additive interaction | 0.099 | 0.104 | |||
Maternal history of CVD† | No history of GDM and no maternal CVD | 53,741 | 9.25 | 1.0 (Reference) | 1.0 (Reference) |
History of GDM only | 864 | 13.46 | 1.59 (1.49–1.70) | 1.31 (1.23–1.40) | |
Maternal CVD history only | 98,837 | 11.67 | 1.17 (1.16–1.18) | 1.22 (1.21–1.23) | |
History of GDM and maternal CVD | 1,572 | 18.77 | 2.04 (1.94–2.14) | 1.75 (1.66–1.84) | |
Multiplicative interaction (GDM × CVD) | 1.10 (1.01–1.19) | 1.09 (1.00–1.19) | |||
P for multiplicative interaction | 0.032 | 0.042 | |||
RERI | 0.28 (0.13–0.43) | 0.21 (0.09–0.34) | |||
P for additive interaction | <0.001 | 0.001 |
Model 1: Follow-up time as time scale.
Model 2: Follow-up time as time scale, controlled for time period of first delivery, parity, age at first delivery, education, smoking during pregnancy, cohabitation, residence, country of origin, maternal CVD history, and paternal CVD history.
Model 2: Follow-up time as time scale, controlled for time period of first delivery, parity, age at first delivery, education, smoking during pregnancy, cohabitation, residence, prepregnancy obesity, country of origin, and paternal CVD history.